{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-042223","form_type":"8-K","ticker":"AVTX","cik":"0001534120","company_name":"Avalo Therapeutics, Inc.","filed_at":"2023-12-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.409876+00:00","generated_at":"2026-06-07T09:49:01.499842+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"AVTX stockholders approve reverse stock split with ratio up to 1:250","bullets":["Reverse stock split approved: 34.7M for, 31.6M against, 0.8M abstain (54.8% of votes cast).","Board will determine final ratio between 1:5 and 1:250; split intended to maintain Nasdaq listing.","Annual meeting quorum was 34.88% (67.1M of 192.4M shares outstanding).","All five director nominees elected; Ernst & Young ratified as auditor for FY2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-042223","json":"https://secwatch.observer/filing/0001628280-23-042223.json","markdown":"https://secwatch.observer/filing/0001628280-23-042223.md","text":"https://secwatch.observer/filing/0001628280-23-042223.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1534120/000162828023042223/0001628280-23-042223-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1534120/000162828023042223/avtx-20231220.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T09:49:01.499842+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"055836fb1efc4d28a9ba96b222ea5b39921c9df9","claim":"Avalo Therapeutics, Inc. shareholders approved Approval of an Amendment to our Certificate of Incorporation to Effect a Reverse Stock Split at the 2023-12-20 meeting.","evidence_excerpt":"Proposal 2: Approval of an Amendment to our Certificate of Incorporation to Effect a Reverse Stock Split","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1534120/000162828023042223/0001628280-23-042223-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"reverse split"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-12-20"}],"fact_type":"shareholder_vote"},{"claim_id":"230896522e3ace505935daa9314dcc91eeea86ae","claim":"Avalo Therapeutics, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2023-12-20 meeting.","evidence_excerpt":"Proposal 3: Ratification of Appointment of Independent Registered Public Accounting Firm","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1534120/000162828023042223/0001628280-23-042223-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-12-20"}],"fact_type":"shareholder_vote"},{"claim_id":"35d6d3dfa64fc6736abc6c1fd56c11daf45a3e83","claim":"Avalo Therapeutics, Inc. shareholders approved Election of Directors at the 2023-12-20 meeting.","evidence_excerpt":"Proposal 1: Election of Directors By the vote reflected below, the Company’s stockholders elected each of the following individuals to the Board to hold office until the 2024 Annual Meeting and until their respective successors are elected and qualified.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1534120/000162828023042223/0001628280-23-042223-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-12-20"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}